ClinicalTrials.govpublic full text
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
multiple sclerosis, progressive multiple sclerosis, ms, edss, tw25, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 902779
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.